Lakeland Regional Medical Center

(863) 687-1100

Lakeland Regional Cancer Center
Lakeland Regional Cancer Center
Lakeland Regional Cancer Center

Print Page

Prostate Cancer

Welcome to LRCC’s Prostate Cancer Center of Excellence

Begun in March, 2011, LRCC’s Prostate Cancer Center of Excellence organizes all efforts and services in prostate care to improve the outcomes of each patient.  This is done through a multidisciplinary approach involving urologic oncologists, radiation oncologists and medical oncologists.  A weekly tumor board involving all of these disciplines reviews the pathology slides and pertinent x-ray studies on all newly diagnosed patients with prostate cancer, and an individualized consensus treatment plan is developed for each patient.  A program navigator assists patients through their appointments, procedures and tests, all while considering the emotional, spiritual and social needs of the patient. 

At LRCC, we believe that knowledge empowers our patients and can help provide hope.  From their first day at our clinic, each patient receives a personal portfolio of educational materials, treatment guides, references and a clinical care calendar.  Currently, a robust data base is being adopted enabling collaboration with other leading cancer centers such as MD Anderson and Memorial Sloan Kettering. 

TREATMENT OPTIONS —  

Robotic Assisted Radical Prostatectomy:

Robotic assisted radical prostatectomy is a minimally invasive surgical procedure that removes the cancerous prostate gland and related structures.  LRCC physicians use the da Vinci Robotic System.  The da Vinci Surgical System consists of an ergonomically designed surgeons’ console, a patient-side cart with four interactive robotic arms, a high-performance vision system and proprietary EndoWrist® Instruments.  Powered by state-of-the-art robotic technology, the surgeon’s hand movements are scaled, filtered and seamlessly translated into precise movements of the EndoWrist® Instruments.  Lakeland Regional Medical Center presently has two state-of-the-art robotic systems.   

The system cannot be programmed, nor can it make decisions on its own.  The da Vinci System requires that every surgical maneuver be performed with direct input from your surgeon.

Robotic surgery is minimally invasive resulting in less pain, less blood loss, less scarring, a shorter recovery time and faster return to normal activities.  It has demonstrated excellent return of sexual function, earlier return of continence and excellent long-term results. 

A robotic prostatectomy requires five small incisions, each about one quarter-of-an-inch in length in the lower abdomen, through which instruments are inserted.  One of these instruments is a video camera which gives a three-dimensional and magnified field of vision making for a more exact operation.

Open Nerve Sparing Radical Prostatectomy:

Open radical prostatectomy involves removal of the prostate, adjacent structures and localized lymph nodes through a mid-line incision in the lower portion of the abdomen.  Open prostatectomy is usually reserved for patients who have had multiple previous abdominal surgeries with scarring or in patients with very large prostates, advanced disease or other urinary problems that require an open surgical approach.  Recovery can be longer than that seen with robotic prostatectomy but long term results with respect to sexual function and continence are equivalent. 

Brachytherapy:

Brachytherapy is radiation therapy that can be used as a treatment for prostate cancer.  Brachytherapy delivers a high and concentrated dose of radiation through a series of radioactive seeds that are implanted in the prostate under anesthesia on an out-patient basis.  Brachytherapy extinguishes the DNA contained within the cancerous cell, preventing it from being able to multiply and copy itself, resulting in the death of the cell.  This procedure is very effective in early prostate cancer cases and is typically used in patients with small tumors confined to a specific region of the prostate.  Brachytherapy is another radiation therapy option to Image Guided Radiation Therapy (IGRT — state-of-the-art external beam radio therapy).

Cryotherapy:

Cryotherapy can be used for treating both prostate cancer and small kidney tumors.   This procedure is performed under anesthesia on an out-patient basis.  A series of needles are placed in the prostate through the perineum (area between the scrotum and rectum) and the prostate and contained cancerous cells are destroyed by the freezing process. 

Focal Therapy:

As part of your evaluation for prostate cancer, it is important to determine if you have highly localized prostate cancer.  Lakeland Reginal Cancer Center has partnered with Radiology and Imaging Specialists to develop dynamic contrast enhanced and diffusion weighted prostate MRI imaging to aid in the evaluation.  This technology affords the patient a 90 percent accuracy rate in identification and localization of prostate cancer.  This study may help determine if you are a candidate for a focal ablation of the tumor, which will enable the rest of your prostate to remain intact.  Focal therapy may preserve your natural function, as well as eliminate your cancer.  One method with which this can be accomplished is Cryotherapy (freezing).

Before making a final decision regarding treatment, we recommend you have a state-of-the-art MRI evaluation and consultation to see if a focal ablation of your prostate cancer is an appropriate option.

ADVANCED MRIS AND DIAGNOSIS OF PROSTATE CANCER —

In conjunction with Radiology and Imaging Specialists, Lakeland Regional Cancer Center uses the most advanced MRI technology to detect prostate tumors early.  Dynamic Contrast Enhanced MRIs allow physicians to view small prostate tumors earlier than regular diagnostic imaging.  This has helped us identify a population of prostate cancer patients who have a small localized area of prostate cancer.  Only about 10 percent of newly diagnosed prostate cancer patients have focal, localized cancer.  This technology has enabled us to offer focal cryoablation of early tumors and spare the remainder of the prostate.  Although these patients must be followed closely, focal ablation therapy has allowed these patients to continue to enjoy normal bladder and sexual function.  Only a small percentage of patients can be properly treated with focal therapy.

LEARN MORE —

To learn more about prostate cancer and robotic surgery, click here.

© 2014 Lakeland Regional Medical Center